B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction

Journal: Nature Communications

Published: 2020-02-26

DOI: 10.1038/s41467-020-14867-z

Affiliations: 13

Authors: 22

Go to article
Institutions Share
Faculty / Graduate School of Medicine, Akita University, Japan 0.41
Biological Resources and Post Harvest Division, JIRCAS, Japan 0.14
Laboratory of Regulation for Intractable Infectious Diseases, NIBIOHN, Japan 0.09
Department of Vascular Physiology, NCVC, Japan 0.09
Faculty / Graduate School of Engineering Science, Akita University, Japan 0.09
Peptide Institute, Inc., Japan 0.09
Akita Research Institute for Food and Brewing (ARIF), Japan 0.05
Institute of Molecular Biotechnology (IMBA), Austria 0.02
Department of Medical Genetics, UBC, Canada 0.02
Life Sciences Institute (LSI), UBC, Canada 0.02

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER